COMPANY NEWS


BSE Code ISIN Demat Book Value (₹) NSE Symbol Div & Yield % Market Cap ( Cr.) P/E * EPS * Face Value (₹)
* Profit to Earning Ratio
* Earning Per Share
Dishman Pharmaceuticals and Chemicals receives EIR from USFDA Back
(02 Feb 2017)
Dishman Pharmaceuticals and Chemicals announced that the Company's Bavla facility was successfully inspected by the US FDA in July, 2016, which was intimated to the stock exchanges on 09 July 2016. In this regard, the Company has received the Establishment Inspection Report (EIR) from the US FDA for this facility on 01 February 2017.

Thus, the Company's facilities in Bavla, Naroda and Switzerland continue to be approved by the US FDA.